Management of ileocolic anastomotic strictures in Crohn's disease: endoscopic or surgical intervention? A systematic review and meta-analysis.

IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Mohamed Talaat Issa, Shafquat Zaman, Ali Yasen Mohamedahmed, Mohammed Hamid, Omar Mostafa, Sangara Narayanasamy, Diwakar Sarma, Rajeev Peravali, Akinfemi Akingboye, Peter Waterland
{"title":"Management of ileocolic anastomotic strictures in Crohn's disease: endoscopic or surgical intervention? A systematic review and meta-analysis.","authors":"Mohamed Talaat Issa, Shafquat Zaman, Ali Yasen Mohamedahmed, Mohammed Hamid, Omar Mostafa, Sangara Narayanasamy, Diwakar Sarma, Rajeev Peravali, Akinfemi Akingboye, Peter Waterland","doi":"10.1007/s00384-025-04958-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Intestinal strictures are one of the most intractable and common complications of Crohn's disease (CD), and their optimal management remains debatable. Endoscopic balloon dilatation (EBD) and stricturoplasty are advanced minimally invasive therapeutic tools in the management of Crohn's strictures and offer an alternative to surgery. We evaluated outcomes following endoscopic intervention compared with surgical resection in the management of ileocolic anastomotic strictures in patients with CD.</p><p><strong>Methods: </strong>A comprehensive and systematic search of various electronic databases was conducted. All studies comparing endoscopic intervention with surgical resection for ileocolic anastomotic strictures in patients with CD were included. Our primary outcomes were re-operation or re-dilatation post-intervention and complications including haemorrhage, perforation, leak, and surgical site infection. Other evaluated parameters included the need to escalate medical treatment following primary intervention. RevMan 5.3 was used to perform the data analysis.</p><p><strong>Results: </strong>Four observational studies with a total of 625 patients were identified and included. This consisted of 355 patients treated surgically and 270 undergoing endoscopic procedures. No significant difference in the risk of re-operation [OR, 0.13; P = 0.19], re-stenosis [OR, 0.58; P = 0.37], or total complications [OR, 1.86; P = 0.34] was seen between the two groups. However, escalation of medical therapy post-intervention was significantly lower in the surgical group compared with those managed endoscopically [OR, 0.19; P = 0.0001].</p><p><strong>Conclusion: </strong>Both surgical and endoscopic treatments are safe and efficacious in managing patients with anastomotic strictures. However, this review emphasises the need for rationally designed, well-powered, randomised controlled trials to establish best practices in treating these challenging patients.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"162"},"PeriodicalIF":2.5000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Colorectal Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00384-025-04958-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Intestinal strictures are one of the most intractable and common complications of Crohn's disease (CD), and their optimal management remains debatable. Endoscopic balloon dilatation (EBD) and stricturoplasty are advanced minimally invasive therapeutic tools in the management of Crohn's strictures and offer an alternative to surgery. We evaluated outcomes following endoscopic intervention compared with surgical resection in the management of ileocolic anastomotic strictures in patients with CD.

Methods: A comprehensive and systematic search of various electronic databases was conducted. All studies comparing endoscopic intervention with surgical resection for ileocolic anastomotic strictures in patients with CD were included. Our primary outcomes were re-operation or re-dilatation post-intervention and complications including haemorrhage, perforation, leak, and surgical site infection. Other evaluated parameters included the need to escalate medical treatment following primary intervention. RevMan 5.3 was used to perform the data analysis.

Results: Four observational studies with a total of 625 patients were identified and included. This consisted of 355 patients treated surgically and 270 undergoing endoscopic procedures. No significant difference in the risk of re-operation [OR, 0.13; P = 0.19], re-stenosis [OR, 0.58; P = 0.37], or total complications [OR, 1.86; P = 0.34] was seen between the two groups. However, escalation of medical therapy post-intervention was significantly lower in the surgical group compared with those managed endoscopically [OR, 0.19; P = 0.0001].

Conclusion: Both surgical and endoscopic treatments are safe and efficacious in managing patients with anastomotic strictures. However, this review emphasises the need for rationally designed, well-powered, randomised controlled trials to establish best practices in treating these challenging patients.

克罗恩病回肠结肠吻合口狭窄的治疗:内镜还是手术?系统回顾和荟萃分析。
背景:肠狭窄是克罗恩病(CD)最棘手、最常见的并发症之一,其最佳治疗方法仍有争议。内窥镜球囊扩张(EBD)和狭窄成形术是治疗克罗恩氏狭窄的先进微创治疗工具,是手术的替代选择。我们评估内镜干预与手术切除治疗cd患者回肠结肠吻合口狭窄的效果。方法:对各种电子数据库进行全面系统的检索。所有比较内镜干预与手术切除治疗CD患者回肠结肠吻合口狭窄的研究均被纳入。我们的主要结果是干预后再手术或再扩张,并发症包括出血、穿孔、泄漏和手术部位感染。其他评估参数包括在初级干预后升级医疗的必要性。采用RevMan 5.3软件进行数据分析。结果:四项观察性研究共纳入625例患者。其中355名患者接受手术治疗,270名患者接受内窥镜治疗。再手术风险差异无统计学意义[OR, 0.13;P = 0.19],再狭窄[OR, 0.58;P = 0.37]或总并发症[or, 1.86;P = 0.34]。然而,与内窥镜治疗组相比,手术组干预后药物治疗的升级明显较低[OR, 0.19;p = 0.0001]。结论:手术和内镜治疗吻合口狭窄安全有效。然而,这篇综述强调需要合理设计、有力的随机对照试验来建立治疗这些具有挑战性的患者的最佳实践。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.90
自引率
3.60%
发文量
206
审稿时长
3-8 weeks
期刊介绍: The International Journal of Colorectal Disease, Clinical and Molecular Gastroenterology and Surgery aims to publish novel and state-of-the-art papers which deal with the physiology and pathophysiology of diseases involving the entire gastrointestinal tract. In addition to original research articles, the following categories will be included: reviews (usually commissioned but may also be submitted), case reports, letters to the editor, and protocols on clinical studies. The journal offers its readers an interdisciplinary forum for clinical science and molecular research related to gastrointestinal disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信